KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 84 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $780,878 | -51.4% | 656,200 | 0.0% | 0.07% | -43.1% |
| Q2 2023 | $1,607,690 | -21.7% | 656,200 | 0.0% | 0.13% | -23.5% |
| Q1 2023 | $2,053,906 | -55.5% | 656,200 | 0.0% | 0.17% | -56.9% |
| Q4 2022 | $4,619,648 | -18.2% | 656,200 | 0.0% | 0.39% | -11.9% |
| Q3 2022 | $5,650,000 | +4.1% | 656,200 | 0.0% | 0.45% | -5.5% |
| Q2 2022 | $5,427,000 | -50.2% | 656,200 | 0.0% | 0.47% | -43.9% |
| Q1 2022 | $10,906,000 | -0.6% | 656,200 | 0.0% | 0.84% | +20.3% |
| Q4 2021 | $10,972,000 | +93.5% | 656,200 | 0.0% | 0.70% | +105.0% |
| Q3 2021 | $5,670,000 | +59.1% | 656,200 | 0.0% | 0.34% | +74.5% |
| Q2 2021 | $3,563,000 | -8.9% | 656,200 | 0.0% | 0.20% | -12.1% |
| Q1 2021 | $3,911,000 | +36.7% | 656,200 | +19.7% | 0.22% | +48.7% |
| Q4 2020 | $2,862,000 | +20.9% | 548,206 | +12.0% | 0.15% | +15.4% |
| Q3 2020 | $2,368,000 | +123.0% | 489,319 | +138.6% | 0.13% | +103.1% |
| Q2 2020 | $1,062,000 | – | 205,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 828,711 | $6,853,000 | 9.51% |
| Prosight Management, LP | 1,262,691 | $10,442,000 | 8.23% |
| CHI Advisors LLC | 1,840,793 | $15,223,000 | 5.81% |
| Ikarian Capital, LLC | 1,408,116 | $11,645,000 | 2.12% |
| Ghost Tree Capital, LLC | 450,000 | $3,722,000 | 1.94% |
| Tri Locum Partners LP | 504,342 | $4,171,000 | 1.71% |
| Ikarian Capital, LLC | 1,075,300 | $8,894,000 | 1.62% |
| Logos Global Management LP | 950,000 | $7,857,000 | 1.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,412,300 | $36,490,000 | 1.39% |
| HealthCor Management, L.P. | 1,209,880 | $10,006,000 | 1.01% |